Budesonide is a corticosteroid. It prevents the release of substances in the body that cause inflammation

Budesonide is used to treat mild to moderate Crohn's disease.

Budesonide belongs to Anti-Asthmatic Therapeutic Category.

Aarti Healthcare Division of Aarti Industries Limited manufactures Budesonide with an annual capacity of 4800 Kgs.

Budesonide available in the following Specifications/Grades.

Specification BP/EP/USP
EDMF (CTD) CEP 2006-295
USDMF 20609
COS RO-CEP 2006-295-REV 01


Aarti Healthcare Division also offers following Intermediates for Budesonide.

Sr. No. Intermediate CAS Number
1 16a-Hydroxyprednisolone 13951-70-7

Budesonide Bambuterol HCL R-Salbutamol Sulphate
Levalbuterol HCL Levalbuterol Tartrate Salmeterol Xinafoate
Ipratropium Bromide Ciclesonide Fluticasone Propionate
Fluticasone Furoate Mometasone Furoate Monohydrate Formoterol Fumarate


Note :

  1. Intermediates of above APIs will be available.
  2. Products Under Patent will not be sold until patent expiration in buyer's country.
  3. Purchase of any Patented Product will be sole responsibility of the Buyer.